Ziprasidone Mesylate Injection, Powder, Lyophilized, For Solution
Product Images NDC 70518-4755

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ziprasidone Mesylate (NDC 70518-4755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Ziprasidone Mesylate Injection 20 mg/mL, lyophilized powder for intramuscular use, packaged as a single-dose vial. The label shows NDC 70518-4755-01, with space for lot number and expiration date. It is repackaged by RemedyRepack Inc., Indiana, PA. Storage and usage instructions include refrigeration and protection from light.*

FDA Label Image

Mm1 (Ziprasidone Mesylate 20mg mL 70518 4755 00)

Label for Ziprasidone Mesylate Injection 20 mg/mL, lyophilized powder for intramuscular use. The label states a quantity of 10 single-dose vials. Labeler information indicates repackaging by RemedyRepack Inc., Indiana, PA. Additional handling and storage instructions are partially visible.*

FDA Label Image

Structure (Structure)

Chemical structure of ziprasidone mesylate, depicted as a molecular diagram showing its ring systems and functional groups, including a chlorine atom and a ketone group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.